Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Avricore Health Inc. V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company’s goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.

TSXV:AVCR - Post Discussion

Avricore Health Inc. > Webinar $AVCR CEO Hector Bremner Tue Jan 9 @ 1PM PT
View:
Post by bmreed on Jan 05, 2024 6:48pm

Webinar $AVCR CEO Hector Bremner Tue Jan 9 @ 1PM PT

Live Webinar - Avricore Health $AVCR w/ CEO Hector Bremner

Tuesday, January 9th at 4PM ET / 1PM PT

Q&A with Radius Research 

Register Here - https://us02web.zoom.us/webinar/register/4517044957352/WN_9bPjlRPzTr2x1qMd17lZMg

 

CEO Hector Bremner will be reviewing the milestones of 2023 and outlook for 2024.

Comment by Optimiststock on Jan 10, 2024 8:08am
How can I get the transcript? Does anyone have the main points of what he said?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities